| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,039 | 0,069 | 07.08. |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| CLOUDR GROUP Aktie jetzt für 0€ handeln | |||||
| 24.07. | CLOUDR (09955): POSITIVE PROFIT ALERT | 2 | HKEx | ||
| 30.06. | CLOUDR (09955): SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO IMPAIRMENT LOSSES RECOGNISED FOR THE YEAR ENDED DECEMBER 31, 2025 | - | HKEx | ||
| 30.06. | CLOUDR (09955): POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON TUESDAY, JUNE 30, 2026 | - | HKEx | ||
| 09.06. | CLOUDR (09955): FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON TUESDAY, JUNE 30, 2026 | - | HKEx | ||
| 09.06. | CLOUDR (09955): NOTICE OF ANNUAL GENERAL MEETING | - | HKEx | ||
| 09.06. | CLOUDR (09955): PROPOSALS FOR (1) GRANTING OF GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES (2) RE-ELECTION OF RETIRING DIRECTORS (3) RE-APPOINTMENT ... | 2 | HKEx | ||
| 11.05. | CLOUDR (09955): POSTPONEMENT OF ANNUAL GENERAL MEETING AND CHANGE OF BOOK CLOSURE PERIOD | - | HKEx | ||
| 29.04. | CLOUDR (09955): ANNUAL REPORT 2025 | - | HKEx | ||
| 26.03. | CLOUDR (09955): ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2025 | - | HKEx | ||
| 16.03. | CLOUDR (09955): DATE OF BOARD MEETING | 1 | HKEx | ||
| 16.02. | CLOUDR (09955): PROFIT WARNING | 2 | HKEx |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BRIGHTSPRING HEALTH SERVICES | 62,43 | +3,02 % | BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., July 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| FRESENIUS | 47,060 | +0,81 % | EQS-Adhoc: Fresenius SE & Co. KGaA: Fresenius hebt aufgrund der starken operativen Geschäftsentwicklung die Ergebnisprognose für das Geschäftsjahr 2026 an | EQS-Ad-hoc: Fresenius SE & Co. KGaA / Schlagwort(e): Prognose / Gesamtjahr
Fresenius SE & Co. KGaA: Fresenius hebt aufgrund der starken operativen Geschäftsentwicklung die Ergebnisprognose... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 39,510 | +1,05 % | Ihre wichtigsten Termine: Spannende Zahlen von: Sony, Moderna, AbbVie, Eaton, ExxonMobil, Linde und Puma! | © Foto: picture alliance / CFOTO | CFOTOGut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag.Untermehmenstermine... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 42,050 | +0,41 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| PROGYNY | 28,140 | -10,30 % | Progyny, Inc. Announces Second Quarter 2026 Results | Reports Record Quarterly Revenue, Gross Profit and Adjusted EBITDARobust Selling Season Activity Continues to Reflect Strong Demand for Women's Health, Family Building SolutionsValue Returned to Shareholders... ► Artikel lesen | |
| BILLIONTOONE | 93,34 | -37,76 % | BillionToOne sinks as outlook unchanged despite surging revenue | ||
| CARL ZEISS MEDITEC | 29,900 | +2,05 % | BERENBERG stuft CARL ZEISS MEDITEC AG auf 'Hold' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat das Kursziel für Carl Zeiss Meditec von 30 auf 28 Euro gesenkt und die Einstufung auf "Hold" belassen. Das Geschäftsjahr 2025/26 sei für Carl... ► Artikel lesen | |
| GENEDX | 77,15 | +10,86 % | Cathie Wood's ARK sells Palantir stock, buys GeneDx Holdings | ||
| ALIGNMENT HEALTHCARE | 14,370 | +7,40 % | Can ALHC's Raised 2026 Outlook Offset Heavier Second-Half Spending? | ||
| BETA BIONICS | 15,900 | +12,69 % | Beta Bionics, Inc.: Beta Bionics Announces Second Quarter 2026 Financial Results and Updates Full Year 2026 Guidance | IRVINE, Calif., July 29, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 22,450 | 0,00 % | Privia Health Group, Inc.: Privia Health Reports Strong Second Quarter and Year-to-Date 2026 Results | 2Q'26 Net Income of $9.0M, +236.7% from 2Q'252Q'26 Adjusted EBITDA of $37.4M, +29.1% from 2Q'25Full-Year 2026 Guidance Raised for All Key Financial Metrics ARLINGTON, Va., Aug. 06, 2026 (GLOBE NEWSWIRE)... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 10,805 | +1,36 % | LifeStance Health Group, Inc.: LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook | SCOTTSDALE, Ariz., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| STARLING ONCOLOGY INSTITUTE | 6,400 | 0,00 % | The Oncology Institute Rebrands as Starling Oncology | CERRITOS, Calif., Aug. 03, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. ("TOI" or "the Company"), one of the largest value-based oncology groups in the United States, announced today that... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 20,390 | +1,80 % | Jefferies senkt Kursziel für Procept BioRobotics nach verfehlten Eingriffszahlen | ||
| CONCENTRA GROUP | 33,980 | +11,30 % | Concentra Q2 2026 slides: margin surge drives guidance raise |